• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Tuesday

    3/28/23 1:43:37 PM ET
    $SEV
    $SMR
    $SOLO
    $SPRC
    Auto Manufacturing
    Industrials
    Metal Fabrications
    Industrials
    Get the next $SEV alert in real time by email

     

    During Tuesday, 95 stocks hit new 52-week lows.

    Areas of Interest About Today's 52-Week Lows:

    • The largest company by market cap to hit a new 52-week low was Wipro (NYSE:WIT).
    • Kiromic BioPharma (NASDAQ:KRBP) was the smallest firm by market cap to set a new 52-week low.
    • Monopar Therapeutics (NASDAQ:MNPR)'s stock came under the most pressure, trading down 50.09% to reach a new 52-week low.
    • Athira Pharma (NASDAQ:ATHA) shares rebounded the highest, with shares trading up 0.0%, bouncing back after reaching its new 52-week low.

    Here is a list of stocks that set new 52-week lows on Tuesday:

    • Wipro (NYSE:WIT) shares made a new 52-week low of $4.35 on Tuesday. The stock was down 1.58% for the day.
    • Plug Power (NASDAQ:PLUG) stock drifted down 2.38% on Tuesday morning to hit a new 52-week low of $10.37.
    • Frontier Communications (NASDAQ:FYBR) shares set a new yearly low of $20.77 this morning. The stock was down 3.07% on the session.
    • Harmony Biosciences (NASDAQ:HRMY) shares made a new 52-week low of $29.86 on Tuesday. The stock was down 20.29% for the day.
    • Globalstar (AMEX:GSAT) stock hit a yearly low of $0.97. The stock was up 0.2% for the day.
    • AMTD Digital (NYSE:HKD) stock broke to a new 52-week low of $6.71 on Tuesday. Shares of the company traded down 0.73%.
    • PROCEPT BioRobotics (NASDAQ:PRCT) stock hit $28.23 on Tuesday morning, setting a new 52-week low for a change of down 0.49%.
    • Sterling Check (NASDAQ:STER) shares reached a new 52-week low of $10.57 on Tuesday morning, moving down 3.61%.
    • Nexters (NASDAQ:GDEV) stock hit a new 52-week low of $3.10. The stock was up 13.21% on the session.
    • Xometry (NASDAQ:XMTR) stock dropped to a yearly low on Tuesday of $13.98. Shares traded down 2.4%.
    • Allego (NYSE:ALLG) stock hit a new 52-week low of $2.19. The stock was down 1.35% on the session.
    • NuScale Power (NYSE:SMR) shares made a new 52-week low of $8.10 on Tuesday. The stock was down 2.13% for the day.
    • iHeartMedia (NASDAQ:IHRT) stock dropped to a yearly low on Tuesday of $3.70. Shares traded down 8.16%.
    • Editas Medicine (NASDAQ:EDIT) shares hit a yearly low of $7.26. The stock was down 1.81% on the session.
    • India Fund (NYSE:IFN) stock achieved a new 52-week low on Tuesday morning, hitting $14.48 and moving down 0.68%.
    • American Software (NASDAQ:AMSWA) stock set a new 52-week low of $12.00 on Tuesday, moving down 1.31%.
    • Eaton Vance Tax-Managed (NYSE:ETB) stock hit a yearly low of $12.70. The stock was down 0.47% for the day.
    • Tremor Intl (NASDAQ:TRMR) stock broke to a new 52-week low of $5.09 on Tuesday. Shares of the company traded down 1.71%.
    • Hyliion Holdings (NYSE:HYLN) shares made a new 52-week low of $1.98 on Tuesday. The stock was down 4.57% for the day.
    • Aura Biosciences (NASDAQ:AURA) stock achieved a new 52-week low on Tuesday morning, hitting $8.63 and moving up 3.37%.
    • PetMed Express (NASDAQ:PETS) shares were up 1.19% for the day, having made a 52-week low of $15.83.
    • Microvast Holdings (NASDAQ:MVST) stock broke to a new 52-week low of $1.06 on Tuesday. Shares of the company traded down 2.75%.
    • Inogen (NASDAQ:INGN) stock broke to a new 52-week low of $12.09 on Tuesday. Shares of the company traded down 1.7%.
    • Ouster (NYSE:OUST) stock set a new 52-week low of $0.70 on Tuesday, moving down 1.5%.
    • Lilium (NASDAQ:LILM) shares moved down 0.33% on Tuesday to hit a new 52-week low of $0.64, drifting down 0.33%.
    • YS Biopharma Co (NASDAQ:YS) stock hit $2.60 on Tuesday morning, setting a new 52-week low for a change of down 10.6%.
    • Aeva Technologies (NYSE:AEVA) stock set a new 52-week low of $1.09 on Tuesday, moving down 2.65%.
    • Near Intelligence (NASDAQ:NIR) stock hit $3.75 on Tuesday morning, setting a new 52-week low for a change of down 21.57%.
    • Inovio Pharmaceuticals (NASDAQ:INO) shares moved down 6.07% on Tuesday to hit a new 52-week low of $0.80, drifting down 6.07%.
    • Cloopen Group Holding (NYSE:RAAS) shares hit a yearly low of $1.34. The stock was down 4.51% on the session.
    • USCB Financial Holdings (NASDAQ:USCB) stock hit $10.70 on Tuesday morning, setting a new 52-week low for a change of down 1.1%.
    • Cohen & Steers Select (NYSE:PSF) shares moved down 0.34% on Tuesday to hit a new 52-week low of $17.28, drifting down 0.34%.
    • Heron Therapeutics (NASDAQ:HRTX) stock hit a new 52-week low of $1.68. The stock was down 2.02% on the session.
    • Invesco High Income 2023 (NYSE:IHIT) shares moved up 0.26% on Tuesday to hit a new 52-week low of $7.55, drifting up 0.26%.
    • Aadi Bioscience (NASDAQ:AADI) stock broke to a new 52-week low of $6.98 on Tuesday. Shares of the company traded down 3.03%.
    • Meta Materials (NASDAQ:MMAT) stock dropped to a yearly low on Tuesday of $0.44. Shares traded down 3.78%.
    • C4 Therapeutics (NASDAQ:CCCC) shares moved down 1.3% on Tuesday to hit a new 52-week low of $3.32, drifting down 1.3%.
    • Moolec Science (NASDAQ:MLEC) shares made a new 52-week low of $4.30 on Tuesday. The stock was down 0.23% for the day.
    • Edgio (NASDAQ:EGIO) shares hit a yearly low of $0.70. The stock was up 1.26% on the session.
    • Investar Holding (NASDAQ:ISTR) shares reached a new 52-week low of $14.76 on Tuesday morning, moving down 1.39%.
    • Bright Health Gr (NYSE:BHG) stock broke to a new 52-week low of $0.21 on Tuesday. Shares of the company traded down 0.58%.
    • Virgin Orbit Holdings (NASDAQ:VORB) stock dropped to a yearly low on Tuesday of $0.37. Shares traded down 23.48%.
    • Babylon Holdings (NYSE:BBLN) stock hit $5.35 on Tuesday morning, setting a new 52-week low for a change of down 7.12%.
    • Groupon (NASDAQ:GRPN) stock hit $3.58 on Tuesday morning, setting a new 52-week low for a change of down 0.69%.
    • Arrival (NASDAQ:ARVL) stock set a new 52-week low of $0.14 on Tuesday, moving down 6.44%.
    • Yellow (NASDAQ:YELL) stock hit a new 52-week low of $1.91. The stock was down 3.04% on the session.
    • RumbleON (NASDAQ:RMBL) stock hit $5.90 on Tuesday morning, setting a new 52-week low for a change of down 8.47%.
    • Alpine 4 Holdings (NASDAQ:ALPP) shares reached a new 52-week low of $0.45 on Tuesday morning, moving up 0.2%.
    • Athira Pharma (NASDAQ:ATHA) shares set a new yearly low of $2.31 this morning. The stock was 0.0% (flat) on the session.
    • Village Farms Intl (NASDAQ:VFF) shares moved down 0.78% on Tuesday to hit a new 52-week low of $0.80, drifting down 0.78%.
    • Kore Group Holdings (NYSE:KORE) shares were down 12.0% for the day, having made a 52-week low of $1.07.
    • Allarity Therapeutics (NASDAQ:ALLR) shares reached a new 52-week low of $2.14 on Tuesday morning, moving up 2.02%.
    • KULR Tech Gr (AMEX:KULR) shares set a new 52-week low of $0.66. The stock traded down 9.7%.
    • Lee Enterprises (NASDAQ:LEE) stock dropped to a yearly low on Tuesday of $12.43. Shares traded down 0.45%.
    • JOANN (NASDAQ:JOAN) shares were down 3.31% for the day, having made a 52-week low of $1.74.
    • Dave (NASDAQ:DAVE) stock broke to a new 52-week low of $5.82 on Tuesday. Shares of the company traded down 2.5%.
    • Inspirato (NASDAQ:ISPO) shares hit a yearly low of $0.86. The stock was up 1.59% on the session.
    • Clearside Biomedical (NASDAQ:CLSD) stock hit $0.92 on Tuesday morning, setting a new 52-week low for a change of down 1.58%.
    • Electrameccanica Vehicles (NASDAQ:SOLO) shares reached a new 52-week low of $0.46 on Tuesday morning, moving down 5.3%.
    • FreightCar America (NASDAQ:RAIL) stock hit $2.94 on Tuesday morning, setting a new 52-week low for a change of down 1.73%.
    • Advanced Emissions Solns (NASDAQ:ADES) stock broke to a new 52-week low of $1.70 on Tuesday. Shares of the company traded up 0.54%.
    • VirTra (NASDAQ:VTSI) shares set a new yearly low of $3.70 this morning. The stock was up 0.02% on the session.
    • Rubicon Technologies (NYSE:RBT) stock dropped to a yearly low on Tuesday of $0.64. Shares traded down 11.41%.
    • Exela Technologies (NASDAQ:XELA) stock drifted down 3.37% on Tuesday morning to hit a new 52-week low of $0.03.
    • Sono Group (NASDAQ:SEV) shares set a new yearly low of $0.33 this morning. The stock was down 4.38% on the session.
    • Fusion Fuel Green (NASDAQ:HTOO) stock hit a new 52-week low of $2.24. The stock was down 2.11% on the session.
    • Dogness (Intl) (NASDAQ:DOGZ) shares hit a yearly low of $0.73. The stock was down 3.93% on the session.
    • Evaxion Biotech (NASDAQ:EVAX) shares made a new 52-week low of $0.92 on Tuesday. The stock was down 13.22% for the day.
    • Unity Biotechnology (NASDAQ:UBX) stock drifted down 10.77% on Tuesday morning to hit a new 52-week low of $1.71.
    • SAB Biotherapeutics (NASDAQ:SABS) shares made a new 52-week low of $0.44 on Tuesday. The stock was down 1.88% for the day.
    • Monopar Therapeutics (NASDAQ:MNPR) stock set a new 52-week low of $1.35 on Tuesday, moving down 50.09%.
    • Aceragen (NASDAQ:ACGN) stock dropped to a yearly low on Tuesday of $2.14. Shares traded down 3.3%.
    • Better Therapeutics (NASDAQ:BTTX) stock hit a yearly low of $0.75. The stock was down 6.59% for the day.
    • Future FinTech Gr (NASDAQ:FTFT) stock hit a new 52-week low of $1.10. The stock was down 1.94% on the session.
    • Akari Therapeutics (NASDAQ:AKTX) shares made a new 52-week low of $0.21 on Tuesday. The stock was down 5.79% for the day.
    • Charah Solns (NYSE:CHRA) stock hit a new 52-week low of $3.25. The stock was down 4.4% on the session.
    • Forward Industries (NASDAQ:FORD) stock set a new 52-week low of $0.97 on Tuesday, moving down 0.28%.
    • Conformis (NASDAQ:CFMS) shares reached a new 52-week low of $1.09 on Tuesday morning, moving down 3.51%.
    • Cryptyde (NASDAQ:TYDE) stock hit a yearly low of $0.08. The stock was down 6.95% for the day.
    • WaveDancer (NASDAQ:WAVD) shares set a new 52-week low of $0.25. The stock traded down 1.63%.
    • Clearmind Medicine (NASDAQ:CMND) stock achieved a new 52-week low on Tuesday morning, hitting $1.61 and moving down 18.29%.
    • PolarityTE (NASDAQ:PTE) stock hit $0.58 on Tuesday morning, setting a new 52-week low for a change of down 7.18%.
    • Secoo Holding (NASDAQ:SECO) shares were down 2.66% for the day, having made a 52-week low of $0.53.
    • TC BioPharm (Holdings) (NASDAQ:TCBP) stock hit a yearly low of $1.46. The stock was down 4.27% for the day.
    • IT Tech Packaging (AMEX:ITP) shares moved down 4.09% on Tuesday to hit a new 52-week low of $0.37, drifting down 4.09%.
    • Agrify (NASDAQ:AGFY) shares fell to $0.15 on Tuesday, setting a new 52-week low with a shift of up 5.0%.
    • Vyant Bio (NASDAQ:VYNT) shares set a new 52-week low of $0.59. The stock traded down 6.25%.
    • Assure Hldgs (NASDAQ:IONM) shares fell to $3.02 on Tuesday, setting a new 52-week low with a shift of down 8.11%.
    • SciSparc (NASDAQ:SPRC) shares hit a yearly low of $0.47. The stock was down 6.86% on the session.
    • Kiromic BioPharma (NASDAQ:KRBP) shares reached a new 52-week low of $3.70 on Tuesday morning, moving down 3.08%.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $SEV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SEV
    $SMR
    $SOLO
    $SPRC

    CompanyDatePrice TargetRatingAnalyst
    Monopar Therapeutics Inc.
    $MNPR
    1/9/2026$115.00Overweight
    Morgan Stanley
    Plug Power Inc.
    $PLUG
    1/9/2026$2.00Buy → Hold
    TD Cowen
    iHeartMedia Inc.
    $IHRT
    1/9/2026$3.50Neutral → Sell
    Goldman
    NuScale Power Corporation
    $SMR
    1/9/2026$28.00Underperform → Neutral
    BofA Securities
    Akari Therapeutics plc
    $AKTX
    1/5/2026$1.00Buy
    Ladenburg Thalmann
    SAB Biotherapeutics Inc.
    $SABS
    12/19/2025$15.00Buy
    Guggenheim
    Globalstar Inc.
    $GSAT
    12/16/2025$62.00Hold
    Deutsche Bank
    PROCEPT BioRobotics Corporation
    $PRCT
    12/12/2025$62.00Buy
    UBS
    More analyst ratings

    $SEV
    $SMR
    $SOLO
    $SPRC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TGE's New Film: "Scare Out" - China's First Contemporary National-Security Movie, Set for Lunar New Year Release

    PARIS,  NEW YORK and LONDON, Feb. 6, 2026 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE:AMTD, SGX: HKB)), AMTD Digital Inc. (NYSE:HKD) and The Generation Essentials Group (", TGE", , NYSE:TGE, LSE: TGE), a subsidiary of AMTD Digital Inc., jointly announce that TGE latest's release "Scare Out" (the "Movie"), China's first contemporary national-security film created under the guidance of the Ministry of State Security of the People's Republic of China, will debut in theatres during 2026 Lunar New Year, releasing on February 17 in China, the United States, Canada, the United Kingdom, Australia, New Zealand, Singapore, Malaysia, Brunei, Ireland, Fiji, and Papua New Guinea

    2/6/26 8:54:00 AM ET
    $AMTD
    $HKD
    $TGE
    Finance: Consumer Services
    Finance
    Newspapers/Magazines
    Consumer Discretionary

    Polyrizon Signs an Agreement to Develop Intranasal Proprietary Non-Hallucinogenic Neuroplastogen Formulation

    Collaboration aims to leverage Polyrizon's advanced proprietary intranasal delivery platform to support clinical development of Clearmind's drug candidate proprietary MEAI Raanana, Israel, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ:PLRZ) ("Polyrizon" or the "Company"), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced that it has entered into a development agreement with Clearmind Medicine Inc. (NASDAQ:CMND) ("Clearmind"), a clinical‑stage biopharmaceutical company focused on the discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems. Under this agreement, Polyr

    2/6/26 7:55:00 AM ET
    $CMND
    $PLRZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI

    Collaboration aims to enhance bioavailability and support clinical advancement of Clearmind's lead MEAI candidate for addiction-related and other CNS disorders Vancouver, Canada, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced that it has entered into a development agreement with Polyrizon Ltd. (NASDAQ:PLRZ) ("Polyrizon"), a pre-clinical-stage biotechnology company developing advanced intranasal delivery solutions. Under the agreement, Clear

    2/6/26 7:55:00 AM ET
    $CMND
    $PLRZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $SEV
    $SMR
    $SOLO
    $SPRC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: V.P., CFO and Treasurer Millage Timothy R. covered exercise/tax liability with 4,055 shares, decreasing direct ownership by 12% to 30,186 units (SEC Form 4)

    4/A - LEE ENTERPRISES, Inc (0000058361) (Issuer)

    2/6/26 6:31:21 PM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    Director Wycoff W Kirk exercised 7,500 units of Class A Voting Common Stock at a strike of $7.50 (SEC Form 4)

    4 - USCB FINANCIAL HOLDINGS, INC. (0001901637) (Issuer)

    2/6/26 10:24:42 AM ET
    $USCB
    Major Banks
    Finance

    CHIEF EXECUTIVE OFFICER Zamani Payam returned $23,309,623 worth of Class A Common Stock to the company (5,458,928 units at $4.27), closing all direct ownership in the company (SEC Form 4)

    4 - Inspirato Inc (0001820566) (Issuer)

    2/5/26 5:37:08 PM ET
    $ISPO
    Blank Checks
    Finance

    $SEV
    $SMR
    $SOLO
    $SPRC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Vu Quan Anh bought $104,925 worth of shares (1,500 units at $69.95) (SEC Form 4)

    4 - Monopar Therapeutics (0001645469) (Issuer)

    12/29/25 12:15:31 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Officer Crespo Jose Luis bought $87,282 worth of shares (37,300 units at $2.34), increasing direct ownership by 14% to 307,332 units (SEC Form 4)

    4 - PLUG POWER INC (0001093691) (Issuer)

    12/17/25 9:06:21 PM ET
    $PLUG
    Industrial Machinery/Components
    Energy

    Chief Executive Officer Givens John F. Ii bought $108 worth of shares (22 units at $4.92), increasing direct ownership by 0.01% to 328,388 units (SEC Form 4)

    4 - VirTra, Inc (0001085243) (Issuer)

    11/19/25 4:05:35 PM ET
    $VTSI
    Miscellaneous manufacturing industries
    Consumer Discretionary

    $SEV
    $SMR
    $SOLO
    $SPRC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Morgan Stanley initiated coverage on Monopar Therapeutics with a new price target

    Morgan Stanley initiated coverage of Monopar Therapeutics with a rating of Overweight and set a new price target of $115.00

    1/9/26 9:05:54 AM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Plug Power downgraded by TD Cowen with a new price target

    TD Cowen downgraded Plug Power from Buy to Hold and set a new price target of $2.00

    1/9/26 8:51:22 AM ET
    $PLUG
    Industrial Machinery/Components
    Energy

    iHeartMedia downgraded by Goldman with a new price target

    Goldman downgraded iHeartMedia from Neutral to Sell and set a new price target of $3.50

    1/9/26 8:49:51 AM ET
    $IHRT
    Broadcasting
    Consumer Discretionary

    $SEV
    $SMR
    $SOLO
    $SPRC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNRELEF KIT issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug ZYNRELEF KIT (SUPPL-18) with active ingredient BUPIVACAINE; MELOXICAM has changed to 'Approval' on 11/21/2024. Application Category: NDA, Application Number: 211988, Application Classification: Labeling

    11/22/24 4:36:11 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for APONVIE issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug APONVIE (SUPPL-3) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 216457, Application Classification: Labeling

    3/11/24 4:38:31 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for CINVANTI issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug CINVANTI (SUPPL-15) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 209296, Application Classification: Labeling

    3/11/24 4:38:29 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $SEV
    $SMR
    $SOLO
    $SPRC
    SEC Filings

    View All

    SEC Form F-3 filed by Fusion Fuel Green PLC

    F-3 - Fusion Fuel Green PLC (0001819794) (Filer)

    2/6/26 5:23:06 PM ET
    $HTOO
    Industrial Machinery/Components
    Energy

    SEC Form DEFA14A filed by Plug Power Inc.

    DEFA14A - PLUG POWER INC (0001093691) (Filer)

    2/6/26 4:47:47 PM ET
    $PLUG
    Industrial Machinery/Components
    Energy

    Amendment: SEC Form SCHEDULE 13G/A filed by Monopar Therapeutics Inc.

    SCHEDULE 13G/A - Monopar Therapeutics (0001645469) (Subject)

    2/6/26 9:54:43 AM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $SEV
    $SMR
    $SOLO
    $SPRC
    Leadership Updates

    Live Leadership Updates

    View All

    Plug Power Calls on Stockholders to Act Now and Vote in Favor of Proposals at January 29, 2026 Special Meeting

    SLINGERLANDS, N.Y., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ:PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, encourages stockholders to vote their shares ahead of the Company's Special Meeting of Stockholders (the "Special Meeting") scheduled for January 29, 2026. The Special Meeting includes proposals that are critical to supporting the Company's ongoing operations, financial flexibility and long-term growth strategy. The Board of Directors urges stockholders of record as of December 12, 2025 (the "Record Date") to vote their shares in favor of all proposals presented at the Special Meeting. This Special Meeting follows the Company's

    1/27/26 2:14:23 PM ET
    $PLUG
    Industrial Machinery/Components
    Energy

    Dave Inc. Appoints Nima Khajehnouri to Board of Directors; Announces Board Leadership Transitions

    LOS ANGELES, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Dave Inc. ("Dave" or the "Company") (NASDAQ:DAVE), one of the nation's leading neobanks, today announced that Nima Khajehnouri, a distinguished leader in artificial intelligence and data engineering, has joined its Board of Directors, effective immediately. Mr. Khajehnouri will serve as a member of the Company's Audit Committee. Imran Khan, who has served on the Board since August 2023, is stepping down in conjunction with this appointment. Mr. Khajehnouri brings more than two decades' experience of leading engineering at some of the world's most influential technology companies. He currently serves as Vice President of Engineering at Meta, h

    1/20/26 5:27:46 PM ET
    $DAVE
    Finance: Consumer Services
    Finance

    StandardAero Set to Join S&P MidCap 400

    NEW YORK, Jan. 16, 2026 /PRNewswire/ -- StandardAero Inc. (NYSE:SARO) will replace Frontier Communications Parent Inc. (NASD: FYBR) in the S&P MidCap 400 effective prior to the opening of trading on Thursday, January 22. S&P 500 & S&P 100 constituent Verizon Communications Inc. (NYSE:VZ) is acquiring Frontier Communications Parent in a deal expected to close soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector Jan 22, 2026 S&P MidCap 400 Addition StandardAero SARO Industrials Jan 22, 2026 S&P MidCap 400 Deletion Frontier Communicati

    1/16/26 6:26:00 PM ET
    $FYBR
    $SARO
    $SPGI
    Telecommunications Equipment
    Telecommunications
    Aerospace
    Industrials

    $SEV
    $SMR
    $SOLO
    $SPRC
    Financials

    Live finance-specific insights

    View All

    Dave Reports Preliminary Fourth Quarter and Full Year 2025 Results

    2025 Revenue and Adjusted EBITDA Results are Expected to Exceed the Top-End of Guidance 4Q25 28 DPD Rate Expected to be Within the Range of 1.95%-2.00%, Outperforming Guidance of Below 2.10% Full Earnings Results and 2026 Financial Outlook to Be Discussed on March 2, 2026 at 5:00pm ET LOS ANGELES, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Dave Inc. ("Dave" or the "Company") (NASDAQ:DAVE), one of the nation's leading neobanks, today announced certain preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2025. The Company expects to release full, audited financial results and file its annual report on Form 10-K for the year ended December 31, 2025 on Mar

    2/5/26 4:15:00 PM ET
    $DAVE
    Finance: Consumer Services
    Finance

    Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds

    The following Eaton Vance closed-end funds (the "Funds") announced distributions today as detailed below. Declaration – 2/2/2026 Ex-Date – 2/13/2026 Record – 2/13/2026 Payable – 2/24/2026   Municipal Bond Funds: Fund Ticker Distribution Change From Prior Distribution Closing Market Price – 01/30/26 Distribution Rate at Market Price Eaton Vance California Municipal Income Trust CEV $0.0500 - $10.27 5.84% Eaton Vance Municipal Income Trust EVN $0.0513 - $10.76 5.72%     Taxable Funds: Fund Ticker Distribution Change From Pr

    2/2/26 4:00:00 PM ET
    $CEV
    $EFR
    $EFT
    Finance/Investors Services
    Finance
    Trusts Except Educational Religious and Charitable
    Finance Companies

    Eaton Vance Closed-End Funds Release Estimated Sources of Distributions

    The Eaton Vance closed-end funds listed below released today the estimated sources of their January distributions (each a "Fund"). This press release is issued as required by the Funds' managed distribution plan (Plan) and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make monthly, as noted below, cash distributions to common shareholders, stated in terms of a fixed amount per common share. This information is sent to you for informational purposes only and is an estimate of the sources of the January distribution. It is not determinative of the tax character of a Fund's distributions for th

    1/30/26 2:00:00 PM ET
    $EOI
    $EOS
    $ETB
    Finance/Investors Services
    Finance
    Trusts Except Educational Religious and Charitable
    Investment Bankers/Brokers/Service

    $SEV
    $SMR
    $SOLO
    $SPRC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Monopar Therapeutics Inc.

    SC 13D/A - Monopar Therapeutics (0001645469) (Subject)

    12/17/24 5:01:42 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/13/24 10:39:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Frontier Communications Parent Inc.

    SC 13D/A - Frontier Communications Parent, Inc. (0000020520) (Subject)

    12/12/24 4:15:11 PM ET
    $FYBR
    Telecommunications Equipment
    Telecommunications

    $SEV
    $SMR
    $SOLO
    $SPRC
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Breaking: Stock Acquired at Athira Pharma Inc. on Jun 25

    Recently, on June 25, 2024, Director Romano Kelly A bought $100,051 worth of shares in Athira Pharma Inc. This transaction involved acquiring 42,400 units at $2.36 per share, resulting in a significant increase in direct ownership by 111% to 80,715 units. The purchase was disclosed in the SEC Form 4 filing. Insider buying is often considered a bullish signal as insiders may have insights into the company's future performance. It's essential to analyze this insider purchase in conjunction with previous insider transactions to identify any patterns or trends. Taking into account the information from the SEC filings, several other insiders at Athira Pharma Inc. have also been active in the sto

    6/26/24 3:07:15 PM ET
    $ATHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    What Does the Recent Purchase at Monopar Therapeutics Inc. on Jun 21 Indicate?

    Monopar Therapeutics Inc. has recently seen notable insider activity, with Chief Operating Officer Cittadine Andrew purchasing $25,574 worth of shares on June 21st, 2024. This purchase, comprising 32,508 units at $0.79, increased Cittadine's direct ownership by 21% to 186,132 units as reported in the SEC Form 4. When analyzing this transaction alongside other recent insider activities within the company, interesting patterns and trends start to emerge. Looking back, Cittadine Andrew has been consistently adding to his position in Monopar Therapeutics Inc. over the past few months, showcasing a strong conviction in the company's future prospects. On May 31st, Cittadine Andrew made a substan

    6/22/24 8:00:00 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care